ArticleBMJ open2025

Neoadjuvant camrelizumab combined with chemoradiotherapy and watch-and-wait strategy versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced oesophageal squamous cell carcinoma: study protocol of a randomised controlled trial (PALACE-3).

Xipeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.